Insider · CIK 0001324863

Thompson Tommy G

CIK 0001324863 Name as filed on the most recent filing

Filed as Thompson Tommy G (83)

106 transaction lines · from 83 filings · filed 2006-05-04 to 2026-03-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

106 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2015-08-20 P, Open-market purchase TherapeuticsMD, Inc.TXMD 3 lines 67,962, acquired Open Form 4 filing 0001387131-15-002640
2015-08-14 S, Open-market sale Bard C R Inc /NJ/BCR 239,103, disposed Open Form 4 filing 0001225208-15-017091
2015-05-21 S, Open-market sale United Therapeutics CorpUTHR 273,057, disposed Open Form 4 filing 0001127602-15-018104
2015-05-11 P, Open-market purchase TherapeuticsMD, Inc.TXMD 2 lines 36,540, acquired Open Form 4 filing 0001387131-15-001609
2015-04-28 S, Open-market sale Bard C R Inc /NJ/BCR 204,515, disposed Open Form 4 filing 0001225208-15-010593
2015-03-13 S, Open-market sale Centene CorpCNC 1,045,760, disposed Open Form 4 filing 0001071739-15-000039
2015-03-09 P, Open-market purchase Physicians Realty TrustDOC 10,452, acquired Open Form 4 filing 0001209191-15-024442
2015-02-27 S, Open-market sale United Therapeutics CorpUTHR 4 lines 1,152,238, disposed Open Form 4 filing 0001127602-15-008899
2014-12-11 P, Open-market purchase Physicians Realty TrustDOC 30,172, acquired Open Form 4 filing 0001209191-14-075022
2014-09-04 P, Open-market purchase TherapeuticsMD, Inc.TXMD 4 lines 9,551, acquired Open Form 4 filing 0001387131-14-003220
2014-05-27 P, Open-market purchase Physicians Realty TrustDOC 50,000, acquired Open Form 4 filing 0001209191-14-037502
2014-05-08 P, Open-market purchase TherapeuticsMD, Inc.TXMD 50,039, acquired Open Form 4 filing 0001387131-14-001735
2014-05-06 S, Open-market sale United Therapeutics CorpUTHR 42,864, disposed Open Form 4 filing 0001127602-14-016728
2013-08-30 P, Open-market purchase Cytori Therapeutics, Inc.CYTX 10,700, acquired Open Form 4 filing 0001140361-13-034899
2013-08-01 S, Open-market sale United Therapeutics CorpUTHR 76,020, disposed Open Form 4 filing 0001127602-13-024153
2013-07-24 P, Open-market purchase Physicians Realty TrustDOC 150,041, acquired Open Form 4 filing 0001209191-13-037965
2013-04-01 P, Open-market purchase CareView Communications IncCRVW 10,000, acquired Open Form 4 filing 0001387131-13-001109
2013-03-14 P, Open-market purchase TherapeuticsMD, Inc.TXMD 51,000, acquired Open Form 4 filing 0001387131-13-004693
2013-02-19 S, Open-market sale Bard C R Inc /NJ/BCR 20,050, disposed Open Form 4 filing 0001225208-13-004930
2011-08-19 P, Open-market purchase Cytori Therapeutics, Inc.CYTX 2 lines 9,921, acquired Open Form 4 filing 0001140361-11-043315
2009-10-26 P, Open-market purchase AGA Medical Holdings, Inc.AGAM 14,500, acquired Open Form 4 filing 0000914190-10-000019
2009-10-26 S, Open-market sale AGA Medical Holdings, Inc.AGAM 14,500, acquired Open Form 4 filing 0001104659-09-060301
2009-07-01 S, Open-market sale Pure BiosciencePURE 9,031, disposed Open Form 4 filing 0001079973-09-000678
2009-01-12 S, Open-market sale Pure BiosciencePURE 31,348, disposed Open Form 4 filing 0001079973-09-000015
2009-01-09 S, Open-market sale Pure BiosciencePURE 66,476, disposed Open Form 4 filing 0001079973-09-000015
2009-01-08 S, Open-market sale Pure BiosciencePURE 65,700, disposed Open Form 4 filing 0001079973-09-000011
2009-01-08 S, Open-market sale Pure BiosciencePURE 65,700, acquired Open Form 4 filing 0001079973-09-000007
2009-01-07 S, Open-market sale Pure BiosciencePURE 51,060, disposed Open Form 4 filing 0001079973-09-000011
2009-01-07 S, Open-market sale Pure BiosciencePURE 51,060, acquired Open Form 4 filing 0001079973-09-000007
2008-10-22 S, Open-market sale Pure BiosciencePURE 46,088, disposed Open Form 4 filing 0001079973-08-000980
2008-10-21 S, Open-market sale Pure BiosciencePURE 46,800, disposed Open Form 4 filing 0001079973-08-000980
2008-07-25 S, Open-market sale Pure BiosciencePURE 103,000, disposed Open Form 4 filing 0001079973-08-000691
2008-07-24 S, Open-market sale Pure BiosciencePURE 52,000, disposed Open Form 4 filing 0001079973-08-000691
2008-04-01 S, Open-market sale Pure BiosciencePURE 149,645, disposed Open Form 4 filing 0001079973-08-000375
2008-03-25 S, Open-market sale Pure BiosciencePURE 88,550, disposed Open Form 4 filing 0001079973-08-000312
2008-03-24 S, Open-market sale Pure BiosciencePURE 25,100, disposed Open Form 4 filing 0001079973-08-000312
2008-03-14 S, Open-market sale Centene CorpCNC 15,300, disposed Open Form 4 filing 0001140361-08-006806
2008-03-12 P, Open-market purchase Centene CorpCNC 15,300, acquired Open Form 4 filing 0001140361-08-006543
2008-03-03 S, Open-market sale Pure BiosciencePURE 12,500, disposed Open Form 4 filing 0001079973-08-000246
2008-02-04 S, Open-market sale Pure BiosciencePURE 35,685, disposed Open Form 4 filing 0001079973-08-000151

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 45
  • Open-market sale 61
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Thompson Tommy G, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001324863

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.